Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy

BACKGROUND: Double-blind randomized controlled trials have compared patients with chronic obstructive pulmonary disease (COPD) taking triple therapy, which can improve lung function, dyspnea, and quality of life and reduce acute exacerbation and mortality, with those taking long-acting muscarinic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Kuang-Ming, Wang, Jhi-Joung, Ho, Chung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257929/
https://www.ncbi.nlm.nih.gov/pubmed/37309394
http://dx.doi.org/10.2147/COPD.S404039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257929/
https://www.ncbi.nlm.nih.gov/pubmed/37309394
http://dx.doi.org/10.2147/COPD.S404039

Ejemplares similares